Outpatient ADE (cytarabine, daunorubicin, and etoposide) is feasible and effective for the first relapse of pediatric acute myeloid leukemia: A prospective, phase II study-Reference-Cited by-同舟云学术

Outpatient ADE (cytarabine, daunorubicin, and etoposide) is feasible and effective for the first relapse of pediatric acute myeloid leukemia: A prospective, phase II study

Published:2020-07-16 Issue:9 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Garg Arun¹,Ganguly Shuvadeep¹^ORCID,Vishnubhatla Sreenivas²,Chopra Anita³,Bakhshi Sameer¹^ORCID

Affiliation:

1. Department of Medical Oncology Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences New Delhi India

2. Department of Biostatistics All India Institute of Medical Sciences New Delhi India

3. Department of Laboratory Oncology Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences New Delhi India

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28404

Reference24 articles.

1. Cancer Statistics Review 1975–2016—SEER statistics.https://seer.cancer.gov/csr/1975_2016/. Accessed 2 September 2019.

2. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

3. Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial

4. Pediatric acute myeloid leukemia: international progress and future directions

5. The evolution of allogeneic stem cell transplant for children and adolescents with acute myeloid leukemia;Flower A;Clin Adv Hematol Oncol,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving Horizons in Pediatric Leukemia: Novel Insights, Challenges, and the Journey Ahead;Cureus;2024-08-22

2. Early stoppage of empirical antibiotic therapy at clinical improvement in paediatric leukaemia patients with high-risk febrile neutropenia (ESAT-HR-FN study): Study protocol of a single centre investigator initiated randomised open label non-inferiority trial;Heliyon;2024-08

3. Anti-Emetics in Children Receiving Chemotherapy for Solid Tumors and Leukemia: Pharmacology and Optimization of Therapy for Nausea and Vomiting;Pharmaceuticals;2024-05-10

4. Treating Pediatric Acute Promyelocytic Leukemia in India – Key Challenges and Lessons Learned;Indian Journal of Pediatrics;2023-12-30

5. Management Principles and Advances in Therapies of Pediatric Acute Leukemia: A Comprehensive Snapshot;Indian Journal of Pediatrics;2023-11-10